News | News By Subject | News by Disease News By Date | Search News

Chemoprotectant News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
Tesaro (TSRO) Announces Approval Of VARUBY (Oral Rolapitant Tablets) By European Commission (EC)     4/26/2017
Heron (HRTX) Announces FDA Approval Of SUSTOL (Granisetron) Extended-Release Injection For The Prevention Of Chemotherapy-Induced Nausea And Vomiting     8/10/2016
Biologics, Inc. (NC) To Be Exclusive Specialty Pharmacy Provider For Vistogard (Uridine Triacetate)     3/9/2016
Tesaro (TSRO) Announces Inclusion Of VARUBI (Rolapitant) In NCCN Antiemesis Guidelines     9/24/2015
Pluristem Therapeutics (PSTI) and National Institute of Allergy And Infectious Diseases (NIAID) Complete FDA Meeting on PLX-R18 Cells in ARS     9/21/2015
Wellstat Therapeutics Corporation’ New Drug Application For Uridine Triacetate As Antidote To Overexposure To Chemotherapy Drug 5-Fluorouracil (5-FU) Accepted For Review By FDA     9/10/2015
NanoString (NSTG) Release: ESMO Clinical Practice Guidelines For Breast Cancer Recommend The Use Of Prosigna/PAM50 Assay For Determining Potential Benefit From Chemotherapy     9/9/2015
Advaxis, Inc. Presents Preliminary Data From A Phase I/II Trial Of ADXS-HPV In HPV-Associated Anal Cancer In Combination With Chemoradiation Showing Complete Response And No Recurrences To Date In All Treated Patientsa     3/16/2015
NovaDel Pharma (NVD) Comments On Delay In Zensana(TM) Launch, As Announced By Hana Biosciences, Inc. (HNAB)     2/21/2007